Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242829 | SCV000305785 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001000334 | SCV001157061 | benign | Polycystic kidney disease, adult type | 2018-10-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001555655 | SCV001777106 | likely benign | not provided | 2020-10-05 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001292191 | SCV001480915 | likely benign | Polycystic kidney disease | no assertion criteria provided | clinical testing | The PKD1 p.Thr2703= variant was not identified in the literature nor was it identified in the LOVD 3.0 or PKD1-LOVD databases. The variant was identified in dbSNP (ID: rs149879790) as "With Likely benign allele", ClinVar (classified as likely benign by PreventionGenetics), and ADPKD Mutation Database (as likely neutral by Athena Diagnostics). The variant was identified in control databases in 330 of 181400 chromosomes at a frequency of 0.002, increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 180 of 15966 chromosomes (freq: 0.01), Other in 3 of 4834 chromosomes (freq: 0.0006), Latino in 12 of 25804 chromosomes (freq: 0.0005), European in 41 of 73996 chromosomes (freq: 0.0006), Ashkenazi Jewish in 6 of 8472 chromosomes (freq: 0.0007), Finnish in 86 of 15602 chromosomes (freq: 0.006), and South Asian in 2 of 23480 chromosomes (freq: 0.00009); it was not observed in the East Asian population. The p.Thr2703= variant is not expected to have clinical significance because it does not result in a change of amino acid and occurs at a non-highly conserved nucleotide at a known consensus splice site. In addition, in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. | |
Genome Diagnostics Laboratory, |
RCV001555655 | SCV002034188 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001555655 | SCV002036718 | likely benign | not provided | no assertion criteria provided | clinical testing |